How to purchase 0.01% atropine sulfate eye drops correctly

0.01% Atropine Sulfate Eye Drops (EIKANCE), as a low-concentration atropine preparation, has attracted much attention in recent years due to its significant efficacy in controlling the progression of myopia in children. This drug effectively delays the progression of myopia by weakening the activity of the eyeball's regulating muscles and slowing down the growth rate of the eye axis. Although this drug has a relatively mature supply system in overseas markets, it has not yet been officially launched in China and has not been included in the medical insurance catalog. Therefore, patients need to be particularly cautious when purchasing and using it.

When purchasing0.01% Atropine Sulfate Eye Drops, you should first choose formal channels. Since the drug has not yet been fully approved in the country, some patients may obtain it through overseas drug purchase channels. In overseas markets, the common specifications of the original drug EIKANCE are 0.01% concentration, each box contains 30 tubes, each tube is 0.3 ml, and the price is about 600 yuan. The specific price will change due to exchange rate fluctuations. In addition, there are some generic pharmaceutical products on the market, such as 0.01% concentration atropine sulfate eye drops produced by Indian pharmaceutical companies. The specifications are generally 5 ml, and the price per tube is relatively low, about tens of yuan. Although the ingredients of these generic drugs are basically the same as those of the original drugs, their production quality and efficacy stability still need to be fully considered by patients and doctors.

When purchasing, you should pay attention to whether the source of the medicine is legal and avoid buying fake and shoddy products. Obtaining drugs through hospital prescriptions or professional drug agents not only ensures medication safety, but also facilitates obtaining professional medication guidance. In addition, patients need to clarify their own indications. 0.01% atropine sulfate eye drops are mainly used to control the progression of myopia in children and adolescents. Clinical studies have shown that this low-concentration atropine eye drop has a significant effect on slowing down the growth of the axial length of the eye and reducing the rate of myopia progression. It has relatively mild side effects and rarely causes significant pupil enlargement or accommodation disorders. It is suitable for long-term use.

Reference materials:https://www.medsafe.govt.nz/profs/datasheet/e/EikanceEyeDrops.pdf